Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor.
暂无分享,去创建一个
[1] J. Wistrand. Distribution and function of carbonic anhydrase (CA) isozymes in the human eye. Relevance for the design of topical CA inhibitors , 1992 .
[2] I. Leopold,et al. Carbonic anhydrase and the elaboration of bicarbonate ion in the rabbit eye. , 1955, A.M.A. archives of ophthalmology.
[3] A. Heijl,et al. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension. , 1997, Ophthalmology.
[4] L. Mogk,et al. Blood dyscrasias and carbonic anhydrase inhibitors. , 1988, Ophthalmology.
[5] T. Maren,et al. The effect of topically administered carbonic anhydrase inhibitors on aqueous humor dynamics in rabbits. , 1983, American journal of ophthalmology.
[6] F. Biddle. Teratogenesis of acetazolamide in the CBA/J and SWV strains of mice. I. Teratology. , 1975, Teratology.
[7] G Brix,et al. Cerebrovascular reserve capacity in patients with occlusive cerebrovascular disease: assessment with dynamic susceptibility contrast-enhanced MR imaging and the acetazolamide stimulation test. , 1996, Radiology.
[8] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1941 .
[9] N. Buskard,et al. Severe aplastic anemia as a complication of acetazolamide therapy. , 1970, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[10] S. Miyamoto,et al. Effect of MK-507 on aqueous humor dynamics in normal human eyes. , 1994, Japanese journal of ophthalmology.
[11] S. Sheps,et al. Effect of acetazolamide on citrate excretion and formation of renal calculi. , 1957, The New England journal of medicine.
[12] W. M. Layton. Teratogenic action of acetazolamide in golden hamsters. , 1971, Teratology.
[13] M. Back. Transient myopia after use of acetazoleamide (diamox). , 1956, A.M.A. archives of ophthalmology.
[14] A. Munafo,et al. Absence of metabolic effects of the topical carbonic anhydrase inhibitors MK‐927 and sezolamide during two‐week ocular administration to normal subjects , 1991, Clinical pharmacology and therapeutics.
[15] F. Ranelletti,et al. Adverse interaction between acetazolamide and anticholinesterase drugs at the normal and myasthenic neuromuscular junction level. , 1984, International journal of clinical pharmacology, therapy and toxicology.
[16] M. Duffel,et al. Ocular disposition of aminozolamide in the rabbit eye. , 1987, Investigative ophthalmology & visual science.
[17] W. Pierce,et al. Pharmacokinetics, acid-base balance and intraocular pressure effects of ethyloxaloylazolamide--a novel topically active carbonic anhydrase inhibitor. , 1994, Experimental eye research.
[18] G. Bietti,et al. Acetazolamide, metabolic acidosis, and intraocular pressure. , 1975, American journal of ophthalmology.
[19] T. Maren,et al. Carbonic anhydrase inhibitory activity and ocular pharmacology of organic sulfamates. , 1993, The Journal of pharmacology and experimental therapeutics.
[20] A. R. Mackenzie. Acetazolamide-induced renal stone. , 1960, The Journal of urology.
[21] W. M. Grant,et al. Carbonic anhydrase inhibitor side effects. Serum chemical analysis. , 1977, Archives of ophthalmology.
[22] E. Beutler,et al. Can the risk of acetazolamide-induced aplastic anemia be decreased by periodic monitoring of blood cell counts? , 1987, American journal of ophthalmology.
[23] E. Strahlman,et al. A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group. , 1995, Archives of ophthalmology.
[24] M. Rubenstein,et al. Acetazolamide-induced renal calculi. , 1975, The Journal of urology.
[25] Eric Kronning. TRANSIENT MYOPIA FOLLOWING THE USE OF ACETAZOLAMIDE , 1957, Acta ophthalmologica.
[26] C. Chiang,et al. Studies of topical carbonic anhydrase inhibitors: ocular hypotensive effect of thiadiazole derivatives. , 1993, Journal of ocular pharmacology.
[27] D. Panebianco,et al. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. , 1993, Archives of ophthalmology.
[28] W. Pierce,et al. Topically Active Ocular Carbonic Anhydrase Inhibitors: Novel Biscarbonylamidothiadiazole Sulfonamides as Ocular Hypotensive Agents , 1993, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[29] M. Galin,et al. Diamox-induced myopia. , 1962, American journal of ophthalmology.
[30] M. Lubeck. Aplastic anemia following acetazolamide therapy. , 1970, American journal of ophthalmology.
[31] R. Hitchings,et al. The Effects of a Topical Acetazolamide Preparation on Intraocular Pressure in Patients with Ocular Hypertension , 1987 .
[32] B. Becker,et al. Urinary excretion of citrate in humans following administration of acetazolamide (diamox). , 1958, A.M.A. archives of ophthalmology.
[33] F. Macri,et al. The constrictive action of acetazolamide on the iris arteries of the cat. , 1961, Archives of ophthalmology.
[34] A. Bird,et al. Treatment of chronic macular edema with acetazolamide. , 1988, Archives of ophthalmology.
[35] I. Leopold,et al. Effect of acetazoleamide (diamox) on carbonic anhydrase activity of anterior uvea of the rabbit eye. , 1954, A.M.A. archives of ophthalmology.
[36] S. Drance,et al. Effect of acetazolamide on the differential threshold. , 1983, Archives of ophthalmology.
[37] T. Maren,et al. Effect of pH on the ocular distribution of a topical carbonic anhydrase inhibitor. , 1995, Experimental eye research.
[38] L. Ayvazian,et al. A study of the hyperuricemia induced by hydrochlorothiazide and acetazolamide separately and in combination. , 1961, The Journal of clinical investigation.
[39] V. H. Lee,et al. Disposition of pilocarpine in the pigmented rabbit eye , 1982 .
[40] G. Fishman,et al. Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. , 1989, Archives of ophthalmology.
[41] C. Phelps,et al. Ethoxzolamide analogue gel. A topical carbonic anhydrase inhibitor. , 1984, Archives of ophthalmology.
[42] I. S. Weiss. Hirsutism after chronic administration of acetazolamide. , 1974, American journal of ophthalmology.
[43] H. Scheie,et al. Transient myopia after acetazolamide. , 1960, Archives of ophthalmology.
[44] M. Morgan,et al. Thrombocytopenia following acetazolamide (diamox) therapy. , 1956, Journal of the American Medical Association.
[45] N. Pfeiffer,et al. Sezolamide: Additivity to timolol twice daily , 1992, Eye.
[46] T. Krupin,et al. Ocular and systemic effects of acetazolamide in nephrectomized rabbits. , 1982, Investigative ophthalmology & visual science.
[47] W. Gill,et al. Causation of stones by 2 co-acting agents--diamox and operative insult upon urinary tract. , 1962, The Journal of urology.
[48] T. Maren,et al. The effect of carbonic anhydrase inhibition on intraocular pressure of rabbits with different blood Co2 equilibria. , 1960, American journal of ophthalmology.
[49] G. Bietti,et al. [Blood acidosis and intraocular hypotension]. , 1972, Klinische Monatsblatter fur Augenheilkunde.
[50] T. Maren,et al. Ocular penetration and hypotensive activity of the topically applied carbonic anhydrase inhibitor L-645,151. , 1986, Journal of ocular pharmacology.
[51] A. Cross,et al. Reduction of macular oedema by acetazolamide in patients with chronic iridocyclitis: a randomised prospective crossover study. , 1994, The British journal of ophthalmology.
[52] B. Matuszewski,et al. Indirect chiral separation and analyses in human biological fluids of the stereoisomers of a thienothiopyran-2-sulfonamide (TRUSOPT), a novel carbonic anhydrase inhibitor with two chiral centers in the molecule. , 1992, Chirality.
[53] D. Jacobowitz,et al. Unequal accumulation of adrenergic drugs by pigmented and nonpigmented iris. , 1974, American journal of ophthalmology.
[54] R. Brown,et al. Acetazolamide and symptomatic metabolic acidosis in mild renal failure. , 1981, British medical journal.
[55] J. Fischbarg,et al. Effects of ambient bicarbonate, phosphate and carbonic anhydrase inhibitors on fluid transport across rabbit corneal endothelium. , 1990, Experimental eye research.
[56] E. Block,et al. Carbonic anhydrase inhibition in glaucoma: hazard or benefit for the chronic lunger? , 1978, Survey of ophthalmology.
[57] C. Phelps,et al. Aminozolamide gel. A trial of a topical carbonic anhydrase inhibitor in ocular hypertension. , 1986, Archives of ophthalmology.
[58] L. Persky,et al. Calculus formation and ureteral colic following acetazolamide (diamox) therapy. , 1956, Journal of the American Medical Association.
[59] T. H. Vickers. Acetazolamide dysmelia in rats. , 1972, British journal of experimental pathology.
[60] H. Melikian,et al. Ocular pigmentation and pressure and outflow responses to pilocarpine and epinephrine. , 1971, American journal of ophthalmology.
[61] Jiunn H. Lin,et al. Uptake and Stereoselective Binding of the Enantiomers of MK-927, a Potent Carbonic Anhydrase Inhibitor, by Human Erythrocytes in Vitro , 1992, Pharmaceutical Research.
[62] S. Podos,et al. MK-507 (L-671,152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys. , 1991, Archives of ophthalmology.
[63] C. Margo. Acetazolamide and advanced liver disease. , 1986, American journal of ophthalmology.
[64] M. Marmor,et al. Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa. , 1994, Ophthalmology.
[65] P. Mallorga,et al. A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals. , 1990, Current eye research.
[66] A. Parfitt. Acetazolamide and sodium bicarbonate induced nephrocalcinosis and nephrolithiasis; relationship to citrate and calcium excretion. , 1969, Archives of internal medicine.
[67] B. Lehmann,et al. The Pharmacokinetics of Acetazolamide in Relation to its Use in the Treatment of Glaucoma and to its Effects as an Inhibitor of Carbonic Anhydrases , 1970 .
[68] C. Binder,et al. Agranulocytosis following diamox therapy. , 1955, Journal of the American Medical Association.
[69] I. Katz,et al. Effects of iris pigmentation on response of ocular pressure to timolol. , 1979, Survey of ophthalmology.
[70] D. Krohn,et al. Pilocarpine uptake by pigmented uveal tissue. , 1973, American journal of ophthalmology.
[71] A. Critchlow,et al. Potassium supplements during treatment of glaucoma with acetazolamide. , 1984, British medical journal.
[72] M. Kass,et al. Acetazolamide and urolithiasis. , 1981, Ophthalmology.
[73] C. A. Stone,et al. On the pharmacology of L-645,151: a topically effective ocular hypotensive carbonic anhydrase inhibitor. , 1985, The Journal of pharmacology and experimental therapeutics.
[74] G. Peyman,et al. Vitreoretinal toxicity of acetazolamide following intravitreal administration in the rabbit eye. , 1994, Ophthalmic surgery.
[75] R. Lewis,et al. 6-Amino-2-Benzothiazolesulfonamide , 1988 .
[76] J. Schuman,et al. MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors. , 1991, Ophthalmology.
[77] S. Podos,et al. Six week safety study of 2% MK-927 administered twice daily to ocular hypertensive volunteers. , 1992, Journal of ocular pharmacology.
[78] D. Marcus,et al. The mechanism of transient myopia induced by sulfonamide therapy. , 1982, American journal of ophthalmology.
[79] J. McLaren,et al. Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans. , 1997, Archives of ophthalmology.
[80] Werner Eb,et al. Effect of a topical carbonic anhydrase inhibitor, 6-hydroxybenzo[b]thiophene-2-sulfonamide, on intraocular pressure in normotensive subjects. , 1987 .
[81] N. Pfeiffer,et al. A single dose of the topical carbonic anhydrase inhibitor MK-927 decreases IOP in patients. , 1990, The British journal of ophthalmology.
[82] A. Halpern,et al. Transient myopia during treatment with carbonic anhydrase inhibitors. , 1959, American journal of ophthalmology.
[83] A. Tarkkanen,et al. Immunocytochemical localization of carbonic anhydrase, NaK‐ATPase and the bicarbonate chloride exchanger in the anterior segment of the human eye , 1991, Acta ophthalmologica.
[84] A. Bird,et al. TREATMENT OF CYSTOID MACULAR EDEMA WITH ACETAZOLAMIDE IN A PATIENT WITH SERPIGINOUS CHOROIDOPATHY , 1991, Retina.
[85] F. G. Hoffman,et al. Fatal agranulocytosis associated with acetazolamide. , 1960, The New England journal of medicine.
[86] W. M. Grant,et al. Diamox (acetazoleamide) in treatment of glaucoma. , 1954, A M A Archives of Ophthalmology.
[87] J J Baldwin,et al. Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma. , 1989, Journal of medicinal chemistry.
[88] S. Cohen,et al. Significant metabolic acidosis induced by acetazolamide. Not a rare complication. , 1985, Archives of internal medicine.
[89] D. Bienfang. Sector pupillary dilatation with an epinephrine strip. , 1973, American journal of ophthalmology.
[90] W. M. Layton,et al. Deformity of Forelimb in Rats: Association with High Doses of Acetazolamide , 1965, Science.
[91] R. Foss. Local application of diamox; an experimental study of its effect on the intraocular pressure. , 1955, American journal of ophthalmology.
[92] G. Englund. Fatal pancytopenia and acetazolamide therapy. , 1969, JAMA.
[93] Davies Dw. Acetazolamide Therapy with Renal Complications , 1959 .
[94] C. Toris,et al. Hydrostatic pressure of the suprachoroidal space. , 1989, Investigative ophthalmology & visual science.
[95] T. Maren,et al. Carbonic anhydrase: General perspective and advances in glaucoma research , 1987 .
[96] M. Eller,et al. Topical carbonic anhydrase inhibitors. , 1984, Journal of medicinal chemistry.
[97] K. Fujieda,et al. Renal tubular acidosis and skeletal demineralization in patients on long-term anticonvulsant therapy. , 1975, The Journal of pediatrics.
[98] M. Goodfield,et al. Acetazolamide and symptomatic metabolic acidosis in mild renal failure. , 1982, British medical journal.
[99] C. Nielsen. THE EFFECT OF CARBONIC ANHYDRASE INHIBITION ON CENTRAL CORNEAL THICKNESS AFTER CATARACT EXTRACTION , 1980, Acta ophthalmologica.
[100] W. Sly,et al. Failure of acetazolamide to decrease intraocular pressure in patients with carbonic anhydrase II deficiency. , 1985, American journal of ophthalmology-glaucoma.
[101] G. Breinin,et al. Carbonic anhydrase inhibitor acetazoleamide (diamox); a new approach to the therapy of glaucoma. , 1954, A.M.A. archives of ophthalmology.
[102] T. Hasegawa,et al. Binding of dorzolamide and its metabolite, N-deethylated dorzolamide, to human erythrocytes in vitro. , 1994, Drug metabolism and disposition: the biological fate of chemicals.
[103] K. Shepard,et al. 3-substituted thieno[2,3-b][1,4]thiazine-6-sulfonamides. A novel class of topically active carbonic anhydrase inhibitors. , 1994, Journal of Medicinal Chemistry.
[104] B. Becker. Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox; a preliminary report. , 1954, American journal of ophthalmology.
[105] N. Wisch,et al. Aplastic anemia resulting from the use of carbonic anhydrase inhibitors. , 1973, American journal of ophthalmology.
[106] R. Cowan,et al. Metabolic acidosis induced by carbonic anhydrase inhibitors and salicylates in patients with normal renal function. , 1984, British medical journal.
[107] T. Maren,et al. pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors. , 1993, Investigative ophthalmology & visual science.
[108] J. Bertino,et al. Thrombocytopenia and renal lesions associated with acetazoleamide (diamox) therapy. , 1957, A.M.A. archives of internal medicine.
[109] S. Drance,et al. Glaucoma, applied pharmacology in medical treatment , 1984 .
[110] M. F. Sugrue. The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor. , 1996, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[111] A. P. Ferry,et al. Gouty arthritis as a complication of acetazolamide (Diamox) therapy for glaucoma. , 1969, Canadian Journal of Ophthalmology-journal Canadien D Ophtalmologie.
[112] E. Fisher,et al. Renal lesions of sulfonamide type after treatment with acetazolamide (diamox). , 1956, Journal of the American Medical Association.
[113] E. Strahlman,et al. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group. , 1996, Ophthalmology.
[114] J. G. Yates-Bell. Renal Colic and Anuria from Acetazolamide , 1958, British medical journal.
[115] N. Pfeiffer,et al. Comparative tolerability of topical carbonic anhydrase inhibitor MK-927 and its S-enantiomer MK-417 , 1991, Graefe's Archive for Clinical and Experimental Ophthalmology.
[116] B. Becker. The mechanism of the fall in intraocular pressure induced by the carbonic anhydrase inhibitor, diamox. , 1955, American journal of ophthalmology.
[117] D. Panebianco,et al. MK-927, a topical carbonic anhydrase inhibitor. Dose response and reproducibility. , 1990, Archives of ophthalmology.
[118] E. Stefánsson,et al. Topical acetazolamide in 2-hydroxypropyl-beta-cyclodextrin eye drops lowers intraocular pressure in humans , 1994 .
[119] P. Kaufman,et al. Toxicity of combined therapy with carbonic anhydrase inhibitors and aspirin. , 1978, American journal of ophthalmology.
[120] D. Epstein,et al. Decreased libido--a side effect of carbonic anhydrase inhibitor. , 1979, Annals of ophthalmology.
[121] M. Kass,et al. MK-927: a topical carbonic anhydrase inhibitor. Dose response and duration of action. , 1990, Archives of ophthalmology.
[122] T. Maren,et al. The transcorneal permeability of sulfonamide carbonic anhydrase inhibitors and their effect on aqueous humor secretion. , 1983, Experimental eye research.
[123] P. Mallorga,et al. L‐662,583 is a topically effective ocular hypotensive carbonic anhydrase inhibitor in experimental animals , 1990, British journal of pharmacology.
[124] T. Maren,et al. Chemical and pharmacological properties of MK-927, a sulfonamide carbonic anhydrase inhibitor that lowers intraocular pressure by the topical route. , 1990, Experimental eye research.
[125] A. Bar-Ilan. The effects of separate and combined topical treatment with timolol maleate and trifluormethazolamide on the intraocular pressure in normal rabbits. , 1984, Current eye research.
[126] L. Carlson,et al. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. , 1992, Archives of ophthalmology.
[127] L. C. Underwood. Fatal bone marrow depression after treatment with acetazolamide (diamox). , 1956, Journal of the American Medical Association.